Differences in Survival Following Surgery Versus Chemoradiotherapy for Clinical Stage T4a Laryngeal Squamous Cell Carcinoma: A Propensity Score‐Matched Analysis
Head & Neck · 2026
DOI: 10.1002/hed.70114 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Head & Neck, 2026. Verfasst von Beverly J Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Chemoradiotherapy, Carcinoma, Squamous Cell, Laryngectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background
Although laryngeal cancer incidence has declined in the United States, case fatality has risen. The survival equivalence of surgery versus chemoradiotherapy (CRT) for cT4a laryngeal squamous cell carcinoma (LSCC) remains uncertain.
Methods
We conducted a retrospective cohort study of cT4a LSCC patients treated with curative‐intent surgery or CRT using the National Cancer Database (2010–2021). Those receiving neoadjuvant or palliative therapy, or with distant metastases were excluded. Survival was assessed using Kaplan–Meier and Cox models after 1:1 propensity score matching.
Results
Among 3569 patients (mean age 61.0, 708 female), 2437 (68.3%) underwent surgery while 1132 (31.7%) received CRT. In the matched cohort ( n = 452 per arm), median survival was 52.8 (95% CI: 45.6–62.4) versus 37.6 (95% CI: 29.2–45.4) months for surgery versus CRT. Adjusted HR for CRT relative to surgery was 1.26 (95% CI: 1.02–1.57).
Conclusions
Surgery was associated with improved overall survival compared with definitive CRT in patients with T4a LSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, California, USA.
- Department of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Department of Otolaryngology-Head and Neck Surgery, Washington University, St. Louis, Missouri, USA.
- Department of Otolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Beverly J Fu, Karthik Rajasekaran
Zitieren
APA
Fu, B. J., Potter, A. L., Pipkorn, P., Kraimer, K. L., Chen, M. M., Rajasekaran, K., Yang, C. J., & Lee, J. J. (2026). Differences in Survival Following Surgery Versus Chemoradiotherapy for Clinical Stage T4a Laryngeal Squamous Cell Carcinoma: A Propensity Score‐Matched Analysis. Head & Neck. https://doi.org/10.1002/hed.70114
Vancouver
Fu BJ, Potter AL, Pipkorn P, Kraimer KL, Chen MM, Rajasekaran K, et al. Differences in Survival Following Surgery Versus Chemoradiotherapy for Clinical Stage T4a Laryngeal Squamous Cell Carcinoma: A Propensity Score‐Matched Analysis. Head & Neck. 2026. doi:10.1002/hed.70114
BibTeX
@article{Fu2026,
author = {Fu, Beverly J and Potter, Alexandra L and Pipkorn, Patrik and Kraimer, Kristen L and Chen, Michelle M and Rajasekaran, Karthik and Yang, Chi-Fu Jeffrey and Lee, Jake J},
title = {Differences in Survival Following Surgery Versus Chemoradiotherapy for Clinical Stage T4a Laryngeal Squamous Cell Carcinoma: A Propensity Score‐Matched Analysis},
journal = {Head & Neck},
year = {2026},
doi = {10.1002/hed.70114}
}
EUVIMED